Nephro Care India Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹175(194.44%)
Premium (ELP)
Nephro Care India Limited's successfully transitioned to public market status with its listing on NSE on Jul 05, 2024. The IPO mobilized 45,84,000 Shares in cumulative capital, including 45,84,000 Shares for corporate expansion.
The public offering was conducted within the price parameters of ₹85 to ₹90, with minimum investment lots of 1600 shares. subscription activity between Jun 28, 2024 and Jul 02, 2024 demonstrated market reception to the company's valuation and growth narrative.
The allotment process concluded on Jul 03, 2024, finalizing share distribution to successful bidders. The listing represents a transformational event, providing the company with enhanced market visibility, regulatory compliance framework, and access to diversified investor capital.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Regulatory Compliance Risks: The healthcare sector is subject to stringent regulations, and any failure to comply with applicable laws could lead to legal and financial repercussions.
- High Operational Costs: Maintaining advanced medical technology and skilled professionals requires significant investment, which could impact profitability if not managed effectively.
- Patient Dependency: The company's revenue heavily relies on patient volume, and any decline due to changing healthcare policies, competition, or patient preferences could negatively affect business performance.
- Location Dependency: All clinics are in Kolkata, with a major part of the company's revenue coming from the Salt Lake clinic. This makes the business sensitive to any local economic or political changes.
- Expansion Risks: The company's plan to expand into new areas like setting up a hospital could bring fresh challenges and higher risks.
- Reliance on Healthcare Professionals: The business heavily depends on its doctors and healthcare staff. Difficulty in attracting or retaining skilled professionals in the future could negatively impact its operations and growth.
- Dr. Pratim Sengupta
Nephro Care India Limited
Bigshare Services Private Limited